Guretzki H J, Schleicher E, Gerbitz K D, Olgemöller B
Institute for Diabetes Research, Munich, Germany.
Am J Physiol. 1994 Oct;267(4 Pt 1):C946-54. doi: 10.1152/ajpcell.1994.267.4.C946.
We investigated the influence of heparin on the composition of the subendothelial matrix and on endothelial permeability to elucidate the structure-function relationship of matrix composition and permeability. Albumin flux across the confluent endothelial monolayers was used to assess the macromolecular permeability. Lowest values were obtained when 100% serum was used as medium for permeability studies. The endothelial matrix components, fibronectin and basement membrane-associated heparan sulfate proteoglycan (HSPG), were measured by enzyme immunoassay. Treatment of proliferating endothelial cells with heparin (0-900 micrograms/ml) induced a dose-dependent decrease in endothelial HSPG content, whereas the fibronectin content was unaltered. This structural change was accompanied by an increase in albumin permeability. Both heparin effects exhibited similar dose-response curves with half-maximal effects at approximately 5 micrograms/ml heparin. Acute addition of 300 micrograms/ml heparin had no effect on permeability or HSPG content. When endothelial cells were preincubated with an HSPG antiserum, the endothelial permeability increased nearly threefold. Our results indicate that heparin-induced loss of HSPG may cause the increase in endothelial permeability. The data underline the importance of HSPG for the integrity of the endothelial barrier.
我们研究了肝素对内皮细胞下层基质组成以及内皮通透性的影响,以阐明基质组成与通透性之间的结构-功能关系。通过测量白蛋白穿过融合内皮单层的通量来评估大分子通透性。在通透性研究中,以100%血清作为培养基时获得的数值最低。采用酶免疫测定法测量内皮基质成分、纤连蛋白和基底膜相关硫酸乙酰肝素蛋白聚糖(HSPG)。用肝素(0 - 900微克/毫升)处理增殖的内皮细胞,导致内皮HSPG含量呈剂量依赖性降低,而纤连蛋白含量未改变。这种结构变化伴随着白蛋白通透性的增加。肝素的这两种作用表现出相似的剂量反应曲线,在约5微克/毫升肝素时达到最大效应的一半。急性添加300微克/毫升肝素对通透性或HSPG含量没有影响。当内皮细胞与HSPG抗血清预孵育时,内皮通透性增加近三倍。我们的结果表明,肝素诱导的HSPG丢失可能导致内皮通透性增加。这些数据强调了HSPG对内皮屏障完整性的重要性。